AMGN

Amgen
D

AMGN

Arincen67/100B

Amgen balance sheet 1988–2026

Amgen had 13.19B USD in cash and short-term investments on 30 September 2026, against total debt of 54.01B USD: net debt of 40.82B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
13.19B9.13B11.97B10.94B7.63B7.99B6.27B6.04B6.95B3.80B3.24B
Short-term investments
0.000.000.000.001.68B48.00M4.38B2.87B22.36B37.88B34.84B
13.19B9.13B11.97B10.94B9.31B8.04B10.65B8.91B29.30B41.68B38.09B
Cash growth
+39.65%-23.75%+9.40%+17.61%+15.78%-24.51%+19.48%-69.59%-29.69%+9.43%+21.36%
Receivables
10.35B9.57B7.50B7.94B6.39B5.84B4.53B4.06B3.58B3.24B3.17B
Inventory
6.39B6.23B7.00B9.52B4.93B4.09B3.89B3.58B2.94B2.83B2.75B
Other current assets
4.43B4.13B419.00M281.00M355.00M200.00M2.08B1.89B1.79B1.73B2.02B
Total current assets
34.36B29.06B29.03B30.33B22.19B19.39B21.14B18.44B37.62B49.48B46.01B
Property, plant and equipment
8.88B8.52B6.54B5.94B5.43B5.18B4.89B4.93B4.96B4.99B4.96B
Long-term investments
0.006.80B5.36B4.71B0.000.000.000.000.000.000.00
Goodwill and intangibles
38.20B40.96B46.34B51.27B31.61B30.07B31.28B34.12B22.14B23.37B25.03B
Goodwill
18.66B18.68B18.64B18.63B15.53B14.89B14.69B14.70B14.70B14.76B14.75B
Intangible assets
19.54B22.28B27.70B32.64B16.08B15.18B16.59B19.41B7.44B8.61B10.28B
Other non-current assets
14.60B5.25B4.58B4.90B5.90B6.52B5.64B2.22B1.70B2.12B1.63B
Total assets
96.05B90.59B91.84B97.15B65.12B61.17B62.95B59.71B66.42B79.95B77.63B
Accounts payable
20.83B2.37B1.91B1.59B1.57B1.37B1.42B1.37B1.21B1.35B917.00M
Deferred revenue
0.000.000.000.000.000.000.000.000.000.000.00
Short-term debt
2.40B4.60B3.55B1.44B1.59B87.00M91.00M2.95B4.42B1.15B4.40B
Other current liabilities
0.001.44B1.33B1.38B1.10B1.62B1.57B1.55B1.54B1.27B1.36B
Total current liabilities
23.23B25.49B23.10B18.39B15.69B12.18B11.65B12.84B13.49B9.02B11.20B
Long-term debt
51.61B50.01B56.55B63.17B37.35B33.22B32.90B26.95B29.51B34.19B30.19B
Other non-current liabilities
5.58B5.07B4.70B7.01B8.41B9.06B8.99B9.64B10.05B10.34B3.92B
Lease obligations, current
0.000.000.000.000.000.000.000.000.000.000.00
Lease obligations, long-term
0.000.000.000.000.000.000.000.000.000.000.00
Total liabilities
81.70B81.93B85.96B90.92B61.46B54.47B53.54B50.03B53.92B54.71B47.75B
Common stock and paid-in capital
34.28B34.02B33.53B33.07B32.51B32.10B31.80B31.53B31.25B30.99B30.78B
Retained earnings
-19.81B-25.11B-27.59B-26.55B-28.62B-24.60B-21.41B-21.33B-17.98B-5.07B-438.00M
Accumulated other comprehensive income
-125.00M-258.00M-66.00M-289.00M-231.00M-796.00M-985.00M-528.00M-769.00M-679.00M-471.00M
Shareholders' equity
14.35B8.66B5.88B6.23B3.66B6.70B9.41B9.67B12.50B25.24B29.88B
Minority interest
0.000.000.000.000.000.000.000.000.000.000.00
54.01B54.60B60.10B64.61B38.95B33.31B32.99B29.90B33.93B35.34B34.60B
Net cash
-40.82B-45.48B-48.13B-53.67B-29.64B-25.27B-22.34B-20.99B-4.63B6.34B3.49B
Working capital
11.13B3.57B5.93B11.94B6.50B7.20B9.49B5.61B24.13B40.46B34.81B
Book value per share
26.2915.9710.8611.586.7711.6915.9515.8818.8034.3439.62
Tangible book value
-23.85B-32.30B-40.46B-45.04B-27.95B-23.37B-21.87B-24.44B-9.64B1.87B4.85B
Tangible book value per share
-43.68-59.59-74.79-83.71-51.66-40.79-37.06-40.14-14.502.556.43
Current ratio
1.481.141.261.651.411.591.811.442.795.494.11
Debt to equity
3.766.3110.2310.3710.644.973.513.092.711.401.16

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Amgen's cash and debt

Source: Financial Modeling PrepVerified against SEC filings